In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aetna Inc.

www.aetna.com

Latest From Aetna Inc.

Options For Medtechs In A Value-Based Care World

Driven by increasingly cost-conscious payers, health care is shifting from a volume-based model to “value-based care,” now the latest buzzword. In response, the medical device industry has started employing new commercial strategies.

Market Access Medical Device

Amazon-Express Scripts Partnership? PBM Sees Opportunity In Uninsured Market

Express Scripts points to a relatively untapped market of 30m uninsured individuals who could be reached through a collaboration with Amazon if the e-commerce giant ventures into Rx drug sales.

Pharmacy Benefit Management Business Strategies

Gottlieb Defends Accelerated Approval, Scorns Access Limits By Payors

US FDA's accelerated approval pathway is more reliable and has better validated biomarkers than a decade ago, commissioner says, arguing coverage limits on AA products are not in the interest of public health.

Drug Approval Standards Private Payers

Cell And Gene Therapies: Where Few Standard Rules Apply

Manufacturing, distribution and pricing challenges for cell and gene therapies have been mostly hypothetical – until now. But with no industry standards, the first products to win approval are dictating the complex path forward.

Regenerative Medicine Reimbursement
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register